ATP-SENSITIVE POTASSIUM CHANNELS - POTENTIAL-DRUG TARGETS IN NEUROPSYCHOPHARMACOLOGY

被引:9
作者
GEHLERT, DR [1 ]
ROBERTSON, DW [1 ]
机构
[1] LIGAND PHARMACEUT INC, SAN DIEGO, CA USA
关键词
ALZHEIMERS DISEASE; APAMIN; AUTORADIOGRAPHY; CHARYBDOTOXIN; EPILEPSY; GLIBENCLAMIDE NEURODEGENERATION; POTASSIUM CHANNELS; TYPE II DIABETES;
D O I
10.1016/0278-5846(94)90113-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
1. K channels are a diverse and ubiquitous class of proteins that regulate a number of biological functions. 2. Ligands far the study of a variety of K channels are avialable. These include ''openers'' and antagonists for the ATP sensitive K channel and peptide toxins such as apamin and charybdotoxin that block other subtypes. 3. Antagonists of the ATP sensitive K channel are useful in the treatment of type II diabetes while ''openers'' of this channel are being tested in asthma and cardiovascular disease. 4. Intracerebroventricular administration of K channel ''openers'' block experimentally induced seizures in rodents through a hyperpolarization of neurons. K channel openers may also be useful in the treatment of neurodegenerative diseases, pain and cerebral ischemia. 5. A key to the development of psychopharmacological agents to modify brain K channel function is CNS selectivity. The promise of the ATP sensitive K channel openers suggests a bright future for this mechanism.
引用
收藏
页码:1093 / 1102
页数:10
相关论文
共 34 条
[1]   ACTIONS OF BRL-34915 (CROMAKALIM) UPON CONVULSIVE DISCHARGES IN GUINEA-PIG HIPPOCAMPAL SLICES [J].
ALZHEIMER, C ;
TENBRUGGENCATE, G .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1988, 337 (04) :429-434
[2]   SCYLLATOXIN, A BLOCKER OF CA2+-ACTIVATED K+ CHANNELS - STRUCTURE-FUNCTION-RELATIONSHIPS AND BRAIN LOCALIZATION OF THE BINDING-SITES [J].
AUGUSTE, P ;
HUGUES, M ;
MOURRE, C ;
MOINIER, D ;
TARTAR, A ;
LAZDUNSKI, M .
BIOCHEMISTRY, 1992, 31 (03) :648-654
[3]  
DELPOZO E, 1990, PHARMACOL TOXICOL, V67, P182
[4]  
DREYER F, 1990, REV PHYSIOL BIOCH P, V115, P93
[5]   K+ CHANNEL OPENERS DECREASE SEIZURES IN GENETICALLY EPILEPTIC RATS [J].
GANDOLFO, G ;
ROMETTINO, S ;
GOTTESMANN, C ;
VANLUIJTELAAR, G ;
COENEN, A ;
BIDARD, JN ;
LAZDUNSKI, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 167 (01) :181-183
[6]   SUBTYPES OF K+ CHANNELS DIFFERENTIATED BY THE EFFECT OF K+ CHANNEL OPENERS UPON K+ CHANNEL BLOCKER-INDUCED SEIZURES [J].
GANDOLFO, G ;
GOTTESMANN, C ;
BIDARD, JN ;
LAZDUNSKI, M .
BRAIN RESEARCH, 1989, 495 (01) :189-192
[7]   COMPARISON OF THE DISTRIBUTION OF BINDING-SITES FOR THE POTASSIUM CHANNEL LIGANDS [I-125] APAMIN, [I-125] CHARYBDOTOXIN AND [I-125] IODOGLYBURIDE IN THE RAT-BRAIN [J].
GEHLERT, DR ;
GACKENHEIMER, SL .
NEUROSCIENCE, 1993, 52 (01) :191-205
[8]  
GEHLERT DR, 1991, J PHARMACOL EXP THER, V257, P901
[9]   AUTORADIOGRAPHIC LOCALIZATION OF [I-125] CHARYBDOTOXIN BINDING-SITES IN RAT-BRAIN [J].
GEHLERT, DR ;
GACKENHEIMER, SL ;
ROBERTSON, DW .
NEUROSCIENCE LETTERS, 1992, 140 (01) :25-29
[10]   SITE-SPECIFIC MUTATIONS IN A MINIMAL VOLTAGE-DEPENDENT K+ CHANNEL ALTER ION SELECTIVITY AND OPEN-CHANNEL BLOCK [J].
GOLDSTEIN, SAN ;
MILLER, C .
NEURON, 1991, 7 (03) :403-408